FDA Approves Dalbavancin For Pediatric ABSSSI Treatment, Company Announces
July 26, 2021
MedPage Today (7/23, Walker) reported, “Antibiotic dalbavancin (Dalvance), previously approved to treat bacterial skin infections in adults, received FDA approval for the pediatric population from birth, manufacturer AbbVie” announced in a July 23 press r...